文献速递糖尿病肥胖与代谢综合征

代谢减重手术对1型糖尿病肥胖成人减重与血糖控制的影响:多中心回顾性队列研究

Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study.
PubMed 文献 · Diabetes Care · 2026-01-01

该多中心回顾性队列纳入162例1型糖尿病合并肥胖成人,评估代谢减重手术前后体重、每日胰岛素需求、HbA1c及心血管代谢指标变化。术后1年平均总体重减轻百分比为29.7%,胰岛素需求从0.75单位/kg/天降至0.32单位/kg/天,HbA1c从64.0 mmol/mol降至60.0 mmol/mol,LDL、HDL、总胆固醇和甘油三酯均显著改善。体重减轻越多胰岛素需求下降越明显,基线HbA1c越高术后血糖控制越差。

要点

  • 术后1年平均总体重减轻29.7%,胰岛素需求与HbA1c均显著下降。
  • LDL、HDL、总胆固醇和甘油三酯在术后显著改善。
  • 基线HbA1c越高者术后血糖控制越差,体重减轻越多胰岛素需求下降越明显。

核心结论

  • 代谢减重手术与1型糖尿病合并肥胖患者显著代谢改善相关,尤其基线HbA1c和胰岛素需求较高者。

研究设计与样本

  • 多中心回顾性队列研究,纳入162例1型糖尿病合并肥胖成人,评估手术前后体重、每日胰岛素需求、HbA1c及心血管代谢指标,采用纵向模型识别反应决定因素。

主要发现

  • 术后1年平均总体重减轻百分比为29.7%(IQR = 29.4, 30.3)。
  • 每日胰岛素需求从0.75(IQR = 0.58, 1.00)单位/kg/天降至0.32(IQR = 0.23, 0.43)单位/kg/天(P < 0.001)。
  • HbA1c从64.0(IQR = 57.0, 74.0)mmol/mol降至60.0(IQR = 53.4, 68.0)mmol/mol(P < 0.001)。
  • LDL、HDL、总胆固醇和甘油三酯水平术后显著改善(P < 0.001)。
  • 更大的总体重减轻与胰岛素需求降低相关,更高的基线HbA1c与更差的术后血糖控制相关。

临床怎么用

  • 对于1型糖尿病合并肥胖患者,代谢减重手术可显著减轻体重、降低胰岛素需求并改善血糖和血脂。
  • 基线HbA1c较高者术后血糖控制可能仍不理想,需加强术后血糖管理。

局限性

  • 回顾性多中心设计,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of metabolic bariatric surgery (MBS) in people living with type 1 diabetes (T1D) and obesity. RESEARCH DESIGN AND METHODS: From retrospective multicenter data, total weight loss, daily insulin requirement, HbA1c, and cardiometabolic parameters were assessed before and after surgery. Longitudinal models were used to identify response determinants. RESULTS: This study included 162 people living with T1D and obesity. One year after surgery, mean total weight loss percentage was 29.7% (interquartile range [IQR] = 29.4, 30.3). Insulin requirements dropped from 0.75 (IQR = 0.58, 1.00) units/kg/day to 0.32 (IQR = 0.23, 0.43) units/kg/day (P < 0.001), and HbA1c dropped from 64.0 (IQR = 57.0, 74.0) mmol/mol to 60.0 (IQR = 53.4, 68.0) mmol/mol (P < 0.001). LDL, HDL, total cholesterol, and triglyceride levels significantly improved after surgery (P < 0.001). Greater total weight loss was associated with reduced insulin requirements, and higher baseline HbA1c was associated with poorer postsurgery glycemic control. CONCLUSIONS: MBS was associated with substantial metabolic improvement in people with T1D and obesity, in particular in those with high HbA1c and insulin need at baseline.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. van der Meer R, Pazmino S, Steenackers N, et al. Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study. Diabetes Care. 2026. PMID: 41706050. doi:10.2337/dc25-2295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。